P120 IMPACT OF THE AVAILABILITY OF IMMUNEMODULATORS OR INFLIXIMAB ON THE TREATMENT AND DISEASE COURSE IN TWO HOSPITAL COHORTS OF NEWLY-DIAGNOSED CROHN'S DISEASE (CD) PATIENTS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.